Comprehensive genotype‐phenotype correlation in AP‐4 deficiency syndrome; Adding data from a large cohort of Iranian patients. Issue 1 (14th September 2020)

• Record Type: Journal Article
• Authors: Beheshtian, Maryam; Akhtarkhavari, Tara; Mehvari, Sepideh; Mohseni, Marzieh; Fattahi, Zohreh; Abedini, Seyedeh Sedigheh; Arzhangi, Sanaz; Fadaee, Mahsa; Jamali, Payman; Najafipour, Reza; Kalscheuer, Vera M.; Hu, Hao; Ropers, Hans‐Hilger; Najmabadi, Hossein; Kahrizi, Kimia
• Is Part Of: Clinical genetics. Volume 99:Issue 1(2021)
• Page Start: 187
• Page End: 192
• Publication Date: 2020-09-14
• Subjects: AP‐4 deficiency syndrome -- consanguinity -- genotype‐phenotype correlation -- intellectual disability -- Iranian families; Medical genetics -- Periodicals; 616.0420
• DOI: 10.1111/cge.13845
• Languages: English
• ISSNs: 0009-9163

Abstract

Abstract: Mutations in adaptor protein complex‐4 (AP‐4) genes have first been identified in 2009, causing a phenotype termed as AP‐4 deficiency syndrome. Since then several patients with overlapping phenotypes, comprised of intellectual disability (ID) and spastic tetraplegia have been reported. To delineate the genotype‐phenotype correlation of the AP‐4 deficiency syndrome, we add the data from 30 affected individuals from 12 out of 640 Iranian families with ID in whom we detected disease‐causing variants in AP‐4 complex subunits, using next‐generation sequencing. Furthermore, by comparing genotype‐phenotype findings of those affected individuals with previously reported patients, we further refine the genotype‐phenotype correlation in this syndrome. The most frequent reported clinical findings in the 101 cases consist of ID and/or global developmental delay (97%), speech disorders (92.1%), inability to walk (90.1%), spasticity (77.2%), and microcephaly (75.2%). Spastic tetraplegia has been reported in 72.3% of the investigated patients. The major brain imaging findings are abnormal corpus callosum morphology (63.4%) followed by ventriculomegaly (44.5%). Our result might suggest the AP‐4 deficiency syndrome as a major differential diagnostic for unknown hereditary neurodegenerative disorders. Abstract :